Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 1—January 2009
Dispatch

Hepatitis E Virus Genotype 3 Diversity, France

Florence Legrand-Abravanel, Jean-Michel Mansuy, Martine Dubois, Nassim Kamar, Jean-Marie Peron, Lionel Rostaing, and Jacques IzopetComments to Author 
Author affiliations: Institut National de la Santé et de la Recherche Médicale, Toulouse, France (F. Legrand-Abravanel, M. Dubois, L. Rostaing, J. Izopet); Centre Hospitalier Universitaire, Toulouse (F. Legrand-Abravanel, J.-M. Mansuy, M. Dubois, N. Kamar, J.-M. Peron, L. Rostaing, J. Izopet)

Main Article

Table 1

Primers used to amplify the whole hepatitis E virus genotype 3f genome

Fragment size, bp Nucleotide position* Sense primers (5′ → 3′) Antisense primers (5′ → 3′)
990 1–990 TAGGCAGACCACGTATGTGGTCGATGCCATGGA gccggtcccagatRtgSaccggRa
1,294 878–2172 ACAGAGGTGTATGTTAGATCCATATTTGGC GGGGAGAAGTCGCTAGAGAAACCTGATGT
2568 2001–4569 CCCAGCGSCWTTCGCTGACCGG CGGATAAGCCACTGGGGCATGCCRCACT
736 4542–5278 AGTGYGGCATGCCCCAGTGGCTTATCCG GCCGGTGGCGCGGGCAGCATAGGCA
1,480 5003–6484 ACGAATGTYGCGCAGGTYTGTGT cccttrtcctgctgngcattctcgacaga
964 6363–7327 GACAGAATTRATTTCGTCGGC TTTCCMGGGRGCGCGGAACCCCGAA

*Nucleotide position refers to Burma strain, M73218.

Main Article

Page created: November 19, 2010
Page updated: November 19, 2010
Page reviewed: November 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external